These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29695244)

  • 21. Difference in Physician- and Patient-Dependent Factors Contributing to Adenoma Detection Rate and Serrated Polyp Detection Rate.
    Cavicchi M; Tharsis G; Burtin P; Cattan P; Venezia F; Tordjman G; Gillet A; Samama J; Nahon-Uzan K; Karsenti D
    Dig Dis Sci; 2019 Dec; 64(12):3579-3588. PubMed ID: 31471862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection rate and predictive factors of sessile serrated polyps in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; de Pretis G; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex DK; Zappa M; Hassan C;
    Gut; 2017 Jul; 66(7):1233-1240. PubMed ID: 26896459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of colonoscopy-detected serrated polyps with synchronous advanced neoplasia in average-risk individuals.
    Álvarez C; Andreu M; Castells A; Quintero E; Bujanda L; Cubiella J; Salas D; Lanas Á; Carballo F; Morillas JD; Hernández C; Jover R; Sarasqueta C; Enriquéz-Navascués JM; Hernández V; Estévez P; Macenlle R; Sala T; Balaguer F; Pellisé M; Moreira L; Gil I; Peris A; González-Rubio F; Ferrández A; Poves C; Ponce M; Grau J; Serradesanferm A; Ono A; Cruzado J; Pérez-Riquelme F; Alonso-Abreu I; Carrillo-Palau M; Santander C; Díaz Tasende J; Herreros A; Cacho G; Barranco LE; Bessa X;
    Gastrointest Endosc; 2013 Aug; 78(2):333-341.e1. PubMed ID: 23623039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenoma Detection Rate and Colorectal Cancer Risk in Fecal Immunochemical Test Screening Programs : An Observational Cohort Study.
    Zorzi M; Antonelli G; Barbiellini Amidei C; Battagello J; Germanà B; Valiante F; Benvenuti S; Tringali A; Bortoluzzi F; Cervellin E; Giacomin D; Meggiato T; Rosa-Rizzotto E; Fregonese D; Dinca M; Baldassarre G; Scalon P; Pantalena M; Milan L; Bulighin G; Di Piramo D; Azzurro M; Gabbrielli A; Repici A; Rex DK; Rugge M; Hassan C; ; Giacomin A; Buda A; Costa D; Checchin D; Marin R; Patarnello E; Ceriani A; Guido E; Bertomoro P; Merlini N; Murer F; Ntakirutimana E; Benazzato L; Bellocchi MCC
    Ann Intern Med; 2023 Mar; 176(3):303-310. PubMed ID: 36802754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Data quality and colonoscopy performance indicators in the prevalent round of a FIT-based colorectal cancer screening program.
    Lund M; Erichsen R; Valori R; Møller Jensen T; Helle Njor S; Laurberg S; Andersen B;
    Scand J Gastroenterol; 2019 Apr; 54(4):471-477. PubMed ID: 30978128
    [No Abstract]   [Full Text] [Related]  

  • 26. Interval cancer after colonoscopy in the Austrian National Screening Programme: influence of physician and patient factors.
    Waldmann E; Penz D; Šinkovec H; Heinze G; Rinner C; Jiricka L; Majcher B; Hinterberger A; Trauner M; Ferlitsch M
    Gut; 2021 Jul; 70(7):1309-1317. PubMed ID: 33023903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling the Adenoma and Serrated pathway to Colorectal CAncer (ASCCA).
    Greuter MJ; Xu XM; Lew JB; Dekker E; Kuipers EJ; Canfell K; Meijer GA; Coupé VM
    Risk Anal; 2014 May; 34(5):889-910. PubMed ID: 24172539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of adenoma detection rate and proximal serrated polyp detection rate and their effect on post-colonoscopy colorectal cancer mortality in screening patients.
    Zessner-Spitzenberg J; Waldmann E; Jiricka L; Rockenbauer LM; Hinterberger A; Cook J; Asaturi A; Szymanska A; Majcher B; Trauner M; Ferlitsch M
    Endoscopy; 2023 May; 55(5):434-441. PubMed ID: 36482285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of an Endoscopic Quality Improvement Program Focused on Adenoma Detection on Sessile Serrated Adenoma/Polyp Detection.
    Racho RG; Krishna M; Coe SG; Thomas CS; Crook JE; Diehl NN; Wallace MB
    Dig Dis Sci; 2017 Jun; 62(6):1464-1471. PubMed ID: 28444509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Full-spectrum (FUSE) versus standard forward-viewing colonoscopy in an organised colorectal cancer screening programme.
    Hassan C; Senore C; Radaelli F; De Pretis G; Sassatelli R; Arrigoni A; Manes G; Amato A; Anderloni A; Armelao F; Mondardini A; Spada C; Omazzi B; Cavina M; Miori G; Campanale C; Sereni G; Segnan N; Repici A
    Gut; 2017 Nov; 66(11):1949-1955. PubMed ID: 27507903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feasibility and economic assessment of chromocolonoscopy for detection of proximal serrated neoplasia within a population-based colorectal cancer screening programme (CONSCOP): an open-label, randomised controlled non-inferiority trial.
    Hurt C; Ramaraj R; Farr A; Morgan M; Williams N; Philips CJ; Williams GT; Gardner G; Porter C; Sampson J; Hillier S; Heard H; Dolwani S;
    Lancet Gastroenterol Hepatol; 2019 May; 4(5):364-375. PubMed ID: 30885505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The conversion factor for predicting adenoma detection rate from polyp detection rate varies according to colonoscopy indication and patient sex.
    Vojtechova G; Ngo O; Grega T; Kmochova K; Voska M; Buckova B; Majek O; Zavoral M; Suchanek S
    Eur J Cancer Prev; 2020 Jul; 29(4):294-302. PubMed ID: 32543806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of screening and follow-up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC-AIM microsimulation model.
    Fisher DA; Saoud L; Hassmiller Lich K; Fendrick AM; Ozbay AB; Borah BJ; Matney M; Parton M; Limburg PJ
    Cancer Med; 2021 Apr; 10(8):2855-2864. PubMed ID: 33314646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Risk of Colorectal Cancer in Individuals With a History of Serrated Polyps.
    Li D; Liu L; Fevrier HB; Alexeeff SE; Doherty AR; Raju M; Amsden LB; Lee JK; Levin TR; Corley DA; Herrinton LJ
    Gastroenterology; 2020 Aug; 159(2):502-511.e2. PubMed ID: 32277950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyp Sizing Poster Improves Polyp Measurement but not Adenoma Detection Rates by Endoscopists in a Large Community Practice.
    Shaukat A; Shamsi N; Menk J; Church TR; Rank J; Colton JB
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2034-2041. PubMed ID: 30312788
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serrated Lesion Detection in a Population-based Colon Screening Program.
    Chu JE; Hamm J; Gentile L; Telford JJ; Schaeffer DF
    J Clin Gastroenterol; 2022 Mar; 56(3):243-248. PubMed ID: 33780220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy.
    Kahi CJ; Hewett DG; Norton DL; Eckert GJ; Rex DK
    Clin Gastroenterol Hepatol; 2011 Jan; 9(1):42-6. PubMed ID: 20888435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection rates for adenomas, serrated polyps and clinically relevant serrated polyps can be easily estimated by individually calculated detection rate ratios.
    Buerger M; Kasper P; Scheller I; Hofer JH; Toermer H; Stelzer A; Stenschke F; Stollenwerk M; Allo G; Goeser T; Steffen HM; Schramm C
    Scand J Gastroenterol; 2020 Jun; 55(6):745-751. PubMed ID: 32524866
    [No Abstract]   [Full Text] [Related]  

  • 39. Adenoma Detection Rate and Risk for Interval Postcolonoscopy Colorectal Cancer in Fecal Immunochemical Test-Based Screening : A Population-Based Cohort Study.
    Wisse PHA; Erler NS; de Boer SY; den Hartog B; Oudkerk Pool M; Terhaar Sive Droste JS; Verveer C; Meijer GA; Lansdorp-Vogelaar I; Kuipers EJ; Dekker E; Spaander MCW
    Ann Intern Med; 2022 Oct; 175(10):1366-1373. PubMed ID: 36162114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Findings in the distal colorectum are not associated with proximal advanced serrated lesions.
    Kahi CJ; Vemulapalli KC; Snover DC; Abdel Jawad KH; Cummings OW; Rex DK
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):345-51. PubMed ID: 25083562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.